Trade Mark Journal No.2025/037 12 September 2025

WO0000001871873 (5)

Office of origin: United States of America

Date of International Registration:30 July 2025
Date of designation in the UK: 30 July 2025
Image for mark 1871873 ZYRBLEISA

International priority date claimed: 22 July 2025 (United States of America) (99296791)
Class 5
Dermatological pharmaceutical products.

Paradigm Therapeutics, Inc.

Representative: Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C., 1101 K Street, N.W.,, 10th Floor, Washington DC 20005, UNITED STATES OF AMERICA